Home
| GHIT R&D Forum 2024
— Leap from Basics! Rethinking the Needs & Exploring Innovative Solutions for Neglected Diseases —
For the past decade, the GHIT Fund has facilitated partnerships for global health R&D product development between Japanese and non-Japanese entities. As we continue our mission and advance our new strategic plan to accelerate product development and maximize impact, the 2024 GHIT R&D Forum aims to strengthen existing and catalyze new partnerships while fostering in-depth discussions among a diverse group of key stakeholders.
This year, we are pleased to include speakers from both within and beyond our network of current GHIT development partners, providing an excellent opportunity for active exchange and networking with a variety of new and existing partners with expertise in local needs, manufacturing, and technologies. We expect to host participants from NGOs and academia as well as industry executives, researchers, and government officials. Proceedings will be conducted in English.
We hope you will be able to join us and look forward to seeing you in Tokyo in December.
| Date & Time | : December 5th, 2024 09:45 - 18:30 | | Venue | : Tokyo Garden Terrace Kioi Conference | | Entry Fee | : Free | | Language | : English | | Capacity | : 120 people | | Registration |
: Pre-registration is required*
| | Meeting Type |
: In-person meeting (NO virtual attendee available)
|
Program
|
TIME
|
SESSION
| |
09:15
|
Registrations
| |
09:45 -09:50
|
Greetings and Opening Remarks
| |
09:50 - 10:05
|
Keynote Speech — People centered innovation: connecting the dots on innovation, access and delivery —
Dr. Mandeep Dhaliwal, Director, HIV and Health Group, Bureau of Policy and Programme Support, United Nations Development Programme (UNDP)
| |
10:10-11:10
|
Session 1: Needs on TB — From innovation in health technologies to reaching the last mile —
[Confirmed Speakers]
・Dr. Jacob Creswell, Head, Innovations and Grants, Stop TB Partnership
・Dr. Nader Fotouhi, Chief Scientific Officer, TB Alliance [Unavailable]
・Mr. Hirotaka Michiba, Manager, FUJIFILM Corporation
・Mr. Yuta Ohashi, Senior Associate, Toyota Tsusho Corporation [Unavailable]
・Dr. Elana Van Brakel, Medical Director, IAVI
| |
11:20 -12:20
|
Session 2: Linking NTD Innovations with Health Systems for Pandemic Preparedness
[Confirmed Speakers]
・Dr. Masahiro Kajihara, Associate Professor, International Institute for Zoonosis Control, Hokkaido University
・Dr. Charles Mowbray, Discovery Director, Drugs for Neglected Diseases initiative (DNDi)
・Dr. Nobuo Saito, Associate Professor, Institute of Tropical Medicine, Nagasaki University
・Dr. Aya Yajima, Regional Advisor - Neglected Tropical Diseases (NTDs), WHO South-East Asia Region (SEARO) [Video Presentation]
| |
12:20 -13:20
|
Lunch Break
Proposal Writing Seminar/Q&A Session
Booth Exhibition
| |
13:20 -14:20
|
Session 3: Needs on Malaria — Approaches to address geographic variations —
[Confirmed Speakers]
・Prof. Arjen Dondorp, Deputy Director and Head of Malaria & Critical Illness Department, Mahidol-Oxford Tropical Medicine Research Unit (MORU)
・Prof. Osamu Kaneko, Dean and Professor, Institute of Tropical Medicine, Nagasaki University
・Dr. Eizo Takashima, Associate Professor, Ehime University
・Dr. Paul Willis, VP Head of Early Development, Medicines for Malaria Venture
| |
14:20 -14:50
|
Networking Session
| |
14:50-15:15
|
Coffee Break
Booth Exhibition
| |
15: 15- 16:15
|
Session 4: Technologies on the Ground — Adapting new technologies in the context of LMICs —
[Confirmed Speakers]
・Dr. Jeremy Burrows, VP Head of Research Drug Discovery, Medicines for Malaria Venture
・Ms. Mariko Kitahama, Assistant Manager, NEC Corporation
・Dr. Keita Wagatsuma, Assistant Professor, Division of International Health, Graduate School of Medical and Dental Sciences, Niigata University
・Dr. Peter Warner, Senior Program Officer, Bill & Melinda Gates Foundation
| |
16:25 -17:25
|
Session 5: From R&D to Access and Delivery — Connecting for an end-to-end Ecosystem —
[Confirmed Speakers]
・Dr. Ashley Birkett, Global Head, Bacterial & Parasitic Diseases, PATH
・Dr. Timothy Endy, CEPI Program Leader for the Disease X Vaccine Library and Chikungunya Vaccines, CEPI
・Dr. Loice Kikwai, Regulatory Affairs Lead, MARKET ACCESS AFRICA
・Dr. Oumar Ndiaye, R&D and Technology Transfer Specialist, Institut Pasteur de Dakar
| |
17:25 -17:30
|
Closing Remarks
| |
17:30 -18:30
|
Reception Party
|
Please note that agenda and speakers are subject to change.
For more information on the GHIT Fund, please visit our website.
|
|---|
|
|---|
| |
|---|
|
|